Affiliations 

  • 1 Department of Chemistry, University of Petroleum & Energy Studies, Dehradun, 248007, India
  • 2 Department of Chemistry, Uttaranchal University, Dehradun, 248007, India
  • 3 School of Pharmacy and Pharmaceutical Science, Lovely Professional University, Phagwara, India
  • 4 Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia
  • 5 Departamento de Quimica Orgánica, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Av. Vicuna Mackenna 4860, Macul, 7820436, Santiago, Chile
  • 6 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia
  • 7 School of Pharmacy, Suresh Gyan Vihar University, Jaipur, Rajasthan, India
  • 8 Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javadsharifirad@gmail.com
  • 9 Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China. chocs@ha.org.hk
  • 10 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, 2007, Australia. kamal.Dua@uts.edu.au
Cancer Cell Int, 2022 Dec 08;22(1):386.
PMID: 36482329 DOI: 10.1186/s12935-022-02808-3

Abstract

Therapeutic effect of phytochemicals has been emphasized in the traditional medicine owing to the presence of bioactive molecules, such as polyphenols. Luteolin is a flavone belonging to the flavonoid class of polyphenolic phytochemicals with healing effect on hypertension, inflammatory disorders, and cancer due to its action as pro-oxidants and antioxidants. The anticancer profile of luteolin is of interest due to the toxic effect of contemporary chemotherapy paradigm, leading to the pressing need for the development and identification of physiologically benevolent anticancer agents and molecules. Luteolin exerts anticancer activity by downregulation of key regulatory pathways associated with oncogenesis, in addition to the induction of oxidative stress, cell cycle arrest, upregulation of apoptotic genes, and inhibition of cell proliferation and angiogenesis in cancer cells. In this review, we discuss about the anticancer profile of luteolin.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.